About: Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
Creator	Diemberger, Igor Fusaroli, Michele Poluzzi, Elisabetta Raschi, Emanuel
Source	Medline; PMC
abstract	covid:e572dfc89e1db33e834d750d70d54558764081ea#abstract
has issue date	2020-08-26(xsd:dateTime)
bibo:doi	10.1007/s40264-020-00990-9
bibo:pmid	32845443
has license	no-cc
sha1sum (hex)	e572dfc89e1db33e834d750d70d54558764081ea
schema:url	https://doi.org/10.1007/s40264-020-00990-9
resource representing a document's title	Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
has PubMed Central identifier	PMC7447592
has PubMed identifier	32845443
schema:publication	Drug Saf
resource representing a document's body	covid:e572dfc89e1db33e834d750d70d54558764081ea#body_text
is schema:about of	named entity 'unpredictable' named entity 'EVIDENCE' named entity 'DIRECT ORAL ANTICOAGULANTS' named entity 'RAISED' named entity 'direct oral anticoagulants' named entity 'investigated' named entity 'injury' named entity 'Lung' named entity 'post-marketing' named entity 'direct oral anticoagulants' named entity '2, 3' named entity 'pharmacological' named entity 'Pharmacovigilance' named entity 'edoxaban' named entity 'atrial fibrillation' named entity 'pharmacological' named entity 'North American' named entity 'MedDRA' named entity 'genetics' named entity 'positive control' named entity 'ILD' named entity 'warfarin' named entity 'metabolic' named entity 'idiopathic pulmonary fibrosis' named entity 'Food and Drug Administration' named entity 'DOACs' named entity 'skin reactions' named entity 'ILD' named entity 'dabigatran' named entity 'DOACs' named entity 'observational studies' named entity 'ILD' named entity 'pre-clinical' named entity 'hemorrhage' named entity 'confounding factor' named entity 'pneumonitis' named entity 'ILD' named entity 'pulmonary embolism' named entity 'ILD' named entity 'ETNA' named entity 'direct oral anticoagulants' named entity 'cerebrovascular accident' named entity 'DOACs' named entity 'Amiodarone' named entity 'anti-inflammatory' named entity 'sensitivity analyses' named entity 'ILD' named entity 'clinical data' named entity 'ILD' named entity 'antifibrotic' named entity 'ILD' named entity 'case reports' named entity 'ILD' named entity 'amiodarone' named entity 'Direct Oral Anticoagulants' named entity 'oncology' named entity 'DOACs' named entity 'Edoxaban' named entity '2, 3' named entity 'DOACs' named entity 'neoplasia' named entity 'observational studies' named entity 'apixaban' named entity 'tolerability' named entity 'ILD' named entity 'DOACs' named entity 'Lung Disease' named entity 'dabigatran' named entity 'rivaroxaban' named entity 'antifibrotic' named entity 'coronavirus disease 2019' named entity 'rituximab' named entity 'ILD' named entity 'confounders' named entity 'edoxaban' named entity 'ILD' named entity 'pharmacovigilance' named entity 'DOACs'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software